$48.12
-0.05-0.10%
À la fermeture: -
$48.12
0.000.00%
Après les heures de négociation: 5:15 PM EDT
Haemonetics publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
08/07/2025 | HAE | Haemonetics | FY | 2026 | $4.70 | $5.00 | $4.88 | — | — | $1.31B | |
05/08/2025 | HAE | Haemonetics | FY | 2026 | $4.70 | $5.00 | $4.54 | — | — | $1.36B | |
02/06/2025 | HAE | Haemonetics | FY | 2025 | $4.50 | $4.70 | $4.59 | $1.35B | $1.37B | $1.39B | |
11/07/2024 | HAE | Haemonetics | FY | 2025 | $4.45 | $4.75 | $4.59 | $1.38B | $1.41B | $1.40B | |
08/08/2024 | HAE | Haemonetics | FY | 2025 | $4.45 | $4.75 | $4.60 | $1.38B | $1.41B | $1.40B | |
05/09/2024 | HAE | Haemonetics | FY | 2025 | $4.45 | $4.75 | $4.40 | $1.38B | $1.41B | $1.37B | |
02/08/2024 | HAE | Haemonetics | FY | 2024 | $3.90 | $4.00 | $3.89 | $1.29B | $1.31B | $1.27B | |
12/12/2023 | HAE | Haemonetics | FY | 2024 | $3.75 | $3.95 | $3.89 | $1.26B | $1.29B | $1.27B | |
11/02/2023 | HAE | Haemonetics | FY | 2024 | $3.75 | $3.95 | $3.81 | $1.25B | $1.27B | $1.26B | |
08/08/2023 | HAE | Haemonetics | FY | 2024 | $3.60 | $3.90 | $3.59 | $1.24B | $1.27B | $1.24B | |
05/11/2023 | HAE | Haemonetics | FY | 2024 | $3.45 | $3.75 | $3.40 | $1.22B | $1.25B | $1.22B | |
02/07/2023 | HAE | Haemonetics | FY | 2023 | $2.90 | $3.00 | $2.92 | $1.14B | $1.16B | $1.14B | |
11/07/2022 | HAE | Haemonetics | FY | 2023 | $2.70 | $3.00 | $2.79 | $1.11B | $1.14B | $1.09B | |
08/10/2022 | HAE | Haemonetics | FY | 2023 | $2.60 | $2.90 | $2.73 | $1.07B | $1.10B | $1.06B | |
05/10/2022 | HAE | Haemonetics | FY | 2023 | $2.50 | $2.90 | $2.75 | $1.04B | $1.08B | $1.03B | |
02/08/2022 | HAE | Haemonetics | FY | 2022 | $2.45 | $2.55 | $2.53 | $974.92M | $992.33M | $996.92M | |
11/09/2021 | HAE | Haemonetics | FY | 2022 | $2.40 | $2.65 | $2.76 | $983.62M | $1.02B | $1.01B | |
08/11/2021 | HAE | Haemonetics | FY | 2022 | $2.60 | $3.00 | $2.78 | $983.62M | $1.03B | $1.00B | |
05/13/2021 | HAE | Haemonetics | FY | 2022 | $2.60 | $3.00 | $3.48 | $983.62M | $1.03B | $1.02B |
Les dernières prévisions pour Haemonetics (HAE) ont été communiquées le août 7, 2025 pour l'année complète 2026. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $4.70 à $5.00, par rapport à un BPA estimé de $4.88. De plus, Haemonetics a prévu un chiffre d'affaires entre $0.00B et $0.00B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.